Understand · Treat · Recover

Prognosis, Hope and Frequently Asked Questions

An honest outlook can include uncertainty, realistic treatment goals and meaningful reasons for hope.

This guide is educational and does not replace individual medical assessment. Do not start, stop or change treatment without the treating team. Cancer Aware supports patients and families worldwide. Drug approvals, availability, affordability and care pathways vary by country.

Chapter 20 of 20

What shapes the outlook?

Stage, histological subtype, molecular findings, general fitness, residual disease after surgery and treatment response all influence prognosis. Some early epithelial cancers and many germ-cell tumours can be cured. Advanced epithelial cancer often responds well initially but carries a substantial recurrence risk. Low-grade serous disease may follow a prolonged course yet still require repeated treatment.

Using survival statistics carefully

Population survival figures describe groups treated in a particular place and period, not an individual deadline. Five-year relative survival compares survival in a cancer population with a similar general population; it does not mean that life ends at five years. Broad registry categories do not map perfectly to every FIGO stage, and statistics may not fully reflect newer therapies. Ask for an outlook linked to the actual subtype and current response.

Hope can change its focus

Hope may mean cure, a long remission, symptom relief, more time with family or maintaining independence. It is reasonable to ask both “What is the best realistic outcome?” and “What should we prepare for if treatment does not work?” A discussion about future care preferences can occur while active treatment continues.

Questions worth bringing to the next visit

  • Is the current goal cure, prolonged remission, control or relief of symptoms?
  • Which factors in this case make the outlook better or worse?
  • How will we know if treatment is helping enough to continue?
  • What support is available if treatment becomes too burdensome?

Key takeaway

Ask for a personalised outlook and a plan that protects both time and quality of life.

Common questions

Can ovarian cancer be cured, including stage IV?

Some ovarian cancers are curable. Stage IV epithelial disease is usually approached with realistic goals of remission and control; exceptional outcomes occur, but cure should not be promised.

How long can someone live, and what if cancer returns?

There is no single timeline. Subtype, response, health and access to further therapy affect survival; recurrence can still be treated in many cases.

Does a normal CA-125 prove the cancer has gone?

No. It is one part of assessment and is not informative in every tumour.

Is it hereditary or preventable?

Some cases are inherited. Genetic testing can guide family prevention, but no strategy prevents every case.

Can it spread through contact or caregiving?

No. Ovarian cancer is not contagious.

Are surgery and chemotherapy always required?

They are common components, but selected early, borderline or rare tumours need different plans, and fitness can change the balance.

Will immunotherapy help?

It helps selected patients under specific biomarker and treatment-setting criteria; it is not universally appropriate.

Does stopping anticancer treatment mean care stops?

No. Palliative care continues active relief of symptoms and support; hospice or end-of-life services may help when appropriate to needs and local systems.

Sources and further reading